Genetically Determined Metabolites in Graves Disease: Insight From a Mendelian Randomization Study

Yao Tan, Jiayang Yin, Jiamin Cao, Bingyu Xie, Feng Zhang, Wei Xiong · 2023

Read Genetically Determined Metabolites in Graves Disease: Insight From a Mendelian Randomization Study by Yao Tan, Jiayang Yin, Jiamin Cao, Bingyu Xie, Feng Zhang, Wei Xiong (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10729855.txt.

Description

Blood small molecules may push the thyroid into overdrive in Graves disease, and genes can test that push. Yao Tan, Jiayang Yin, Jiamin Cao, Bingyu Xie, Feng Zhang, and Wei Xiong run that test in a 2023 study. They use FinnGen data with 2,836 cases.

Nineteen molecules tied to disease risk at first pass. Ten held up under hard checks. One molecule, kynurenine, raised risk nearly fourfold per unit. Two others cut risk roughly in half. None of the three shared gene roots with the disease itself. That split supports a true causal push, they argue.

Catalog record

CREATORYao Tan, Jiayang Yin, Jiamin Cao, Bingyu Xie, Feng Zhang, Wei Xiong
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE25 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10729855

Browse the full library · About the Tower of Babel